Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial

  • Marco LADETTO
  • , S Vallet
  • , F Benedetti
  • , U Vitolo
  • , M Martelli
  • , V Callea
  • , C Patti
  • , P Coser
  • , A Perrotti
  • , M Sorio
  • , C Boccomini
  • , A Pulsoni
  • , C Stelitano
  • , R Scimè
  • , Mario BOCCADORO
  • , Rosalba ROSATO
  • , Marco F De
  • , MANUELA ZANNI
  • , P Corradini
  • , Corrado TARELLA

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

This study provides an updated report of the consecutive multicenter Gruppo Italiano Trapianto Midollo Osseo trial employing an intensified, purging-free, total body irradiation-free, high-dose sequential chemotherapy schedule with peripheral blood stem cell autograft (i-HDS) in advanced-stage follicular lymphoma (FL). Special interest has been devoted to late toxicities and outcome in terms of molecular status. Ninety-two untreated FL patients aged
Lingua originaleInglese
pagine (da-a)1840-1847
Numero di pagine8
RivistaLeukemia
Volume20
Stato di pubblicazionePubblicato - 2006

Keywords

  • Autologous transplantation
  • Follicular Lymphoma
  • secondary malignancies

Fingerprint

Entra nei temi di ricerca di 'Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial'. Insieme formano una fingerprint unica.

Cita questo